CEBPB and breast cancer: Loss of C/EBPβ was detected in samples of triple-negative human breast cancers, which are characterized by their de-differentiated and invasive nature, and by displaying EMT characteristics, such as loss of E-cadherin.8 This raises the possibility to use staining for C/EBPβ as an additional diagnostic tool to determine invasiveness in human breast cancer.